Medicenna Therapeutics Corp. (MDNA.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 53.24M |
| Enterprise Value | 47.11M |
| P/E Ratio | -1.67 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 12.44 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.98 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.18 |
| Return On Equity | -2.19 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -77,000 |
| EBITDA | -23.63M |
| Net Income | -18.41M |
| Diluted EPS | -0.22 |
Balance Sheet
| Total Cash | 6.25M |
| Total Cash/Share | 0.07 |
| Total Debt | 119,000 |
| Total Debt/Equity | 0.05 |
| Current Ratio | 1.52 |
| Book Value Per Share | 0.03 |
Price History
| 52-Week Change | -55.42 |
| 52-Week High | 1.97 |
| 52-Week Low | 0.36 |
| Moving Average 50 Days | 0.47 |
| Moving Average 200 Days | 0.86 |
Statistics
| Average Volume | 108,525 |
| Shares Outstanding | 77.62M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
